India Globalization Capital IGC shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC.
The company was issued a patent from the United States Patent And Trademark Office titled ‘Ultra-Low Dose THC As A Potential Therapeutic And Prophylactic Agent For Alzheimer’s Disease.’
India Globalization Capital purchases and resells physical infrastructure commodities. The company operates through two segments: Infrastructure Business and Life Sciences. The company operates in the United States, India, Columbia and Hong Kong.
The stock has a 52-week low of $0.54 and a 52-week high of $4.65.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
